Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689883011 | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3689885016 | Codeine phosphate 30 mg and paracetamol 500 mg effervescent powder for oral suspension sachet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3689886015 | Acetaminophen 500 mg and codeine phosphate 30 mg effervescent powder for oral suspension sachet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | est un(e) (attribut) | Product containing only codeine and paracetamol in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | est un(e) (attribut) | Co-codamol (product) | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Plays role | Antitussive therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | a pour principe actif (attribut) | analgésique non opioïde | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | a pour principe actif (attribut) | Acetaminophen | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | est un(e) (attribut) | Acetaminophen + codeine phosphate (product) | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | a pour principe actif (attribut) | Central nervous system agent (substance) | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | a pour principe actif (attribut) | Morphinan opioid | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | a pour principe actif (attribut) | Codeine phosphate | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | a pour principe actif (attribut) | Codeine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | a une forme pharmaceutique (attribut) | poudre orale à libération classique (forme pharmaceutique) | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | est un(e) (attribut) | médicament contenant paracétamol et codéine | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | est un(e) (attribut) | Acetaminophen-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | est un(e) (attribut) | Codeine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | est un(e) (attribut) | Acetaminophen- and codeine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | a une forme pharmaceutique (attribut) | Effervescent powder for oral suspension | true | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has precise active ingredient | Codeine phosphate | true | Inferred relationship | Some | 1 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has precise active ingredient | Acetaminophen | true | Inferred relationship | Some | 2 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has presentation strength numerator value (attribute) | 500 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has presentation strength denominator unit (attribute) | Sachet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has unit of presentation | Sachet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has presentation strength denominator unit (attribute) | Sachet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Acetaminophen | true | Inferred relationship | Some | 2 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Codeine phosphate | true | Inferred relationship | Some | 1 | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | Has presentation strength numerator value (attribute) | 30 (qualifier value) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR